Trial Profile
Retrospective cohort study investigating safety and efficacy of protease inhibitor-triple therapy (PI-TT) in mildly decompensated liver cirrhosis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Liver cirrhosis; Liver failure
- Focus Adverse reactions; Therapeutic Use
- 19 Dec 2015 New trial record